Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $1.15 Million - $1.28 Million
-4,200 Reduced 26.75%
11,500 $351,000
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $328,944 - $409,570
1,400 Added 9.79%
15,700 $508,000
Q1 2022

May 12, 2022

SELL
$221.42 - $260.97 $1.51 Million - $1.77 Million
-6,800 Reduced 32.23%
14,300 $432,000
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $424,824 - $536,280
2,400 Added 12.83%
21,100 $300,000
Q3 2021

Nov 10, 2021

SELL
$181.39 - $202.99 $1.25 Million - $1.4 Million
-6,900 Reduced 26.95%
18,700 $88,000
Q2 2021

Aug 11, 2021

BUY
$187.49 - $221.1 $4.8 Million - $5.66 Million
25,600 New
25,600 $138,000
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $4.14 Million - $4.83 Million
-20,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $4.14 Million - $5.52 Million
20,000 New
20,000 $288,000
Q2 2018

Aug 13, 2018

SELL
$145.72 - $169.96 $7.34 Million - $8.57 Million
-50,400 Closed
0 $0
Q1 2018

May 11, 2018

SELL
$151.6 - $177.13 $6.19 Million - $7.23 Million
-40,800 Reduced 44.74%
50,400 $24,000
Q4 2017

Feb 09, 2018

SELL
$137.28 - $155.55 $31.9 Million - $36.2 Million
-232,700 Reduced 71.84%
91,200 $593,000
Q3 2017

Nov 08, 2017

BUY
$148.13 - $162.24 $48 Million - $52.5 Million
323,900
323,900 $472,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.